换一批
换一批Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
第一作者：
Rima M,Saliba
第一单位：
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: rsaliba@mdanderson.org.
作者：
Rima M,Saliba [1]
;
Amin M,Alousi [2]
;
Joseph,Pidala [3]
;
Mukta,Arora [4]
;
Stephen R,Spellman [5]
;
Michael T,Hemmer [6]
;
Tao,Wang [7]
;
Camille,Abboud [8]
;
Sairah,Ahmed [9]
;
Joseph H,Antin [10]
;
Amer,Beitinjaneh [11]
;
David,Buchbinder [12]
;
Michael,Byrne [13]
;
Jean-Yves,Cahn [14]
;
Hannah,Choe [15]
;
Rabi,Hanna [16]
;
Peiman,Hematti [17]
;
Rammurti T,Kamble [18]
;
Carrie L,Kitko [19]
;
Mary,Laughlin [20]
;
Lazaros,Lekakis [11]
;
Margaret L,MacMillan [21]
;
Rodrigo,Martino [22]
;
Parinda A,Mehta [23]
;
Taiga,Nishihori [24]
;
Sagar S,Patel [25]
;
Miguel-Angel,Perales [26]
;
Hemalatha G,Rangarajan [27]
;
Olov,Ringdén [28]
;
Joseph,Rosenthal [29]
;
Bipin N,Savani [30]
;
Kirk R,Schultz [31]
;
Sachiko,Seo [32]
;
Takanori,Teshima [33]
;
Marjolein,van der Poel [34]
;
Leo F,Verdonck [35]
;
Daniel,Weisdorf [36]
;
Baldeep,Wirk [37]
;
Jean A,Yared [38]
;
Jeffrey,Schriber [39]
;
Richard E,Champlin [2]
;
Stefan O,Ciurea [40]
作者单位：
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: rsaliba@mdanderson.org.
[1]
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
[2]
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
[3]
CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be the Match, Minneapolis, Minnesota; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
[4]
CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.
[5]
CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
[6]
CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Divsion of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
[7]
Washington University in St. Louis School of Medicine, Division of Oncology, Section of BMT and Leukemia, St. Louis, Missouri.
[8]
Department of Lymphoma-Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, Texas.
[9]
Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
[10]
Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, Florida.
[11]
Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, California.
[12]
Vanderbilt University Medical Center, Nashville, Tennessee.
[13]
Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.
[14]
The Ohio State University Wexner Medical Center, James Comprehensive Cancer Center, Columbus, Ohio.
[15]
Cleveland Clinic, Cleveland, Ohio.
[16]
Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin, Madison, Wisconsin.
[17]
Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
[18]
Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
[19]
Medical Director, Cleveland Cord Blood Center, Cleveland, Ohio.
[20]
Blood and Marrow Transplant Program, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
[21]
Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
[22]
Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
[23]
Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, Florida.
[24]
Blood and Marrow Transplant Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
[25]
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
[26]
Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, Ohio.
[27]
Translational Cell Therapy Group, CLINTEC (Clinical Science, Intervention and Technology), Karolinska Institutet, Stockholm, Sweden.
[28]
City of Hope, Duarte, California.
[29]
Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
[30]
Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, British Columbia, Canada.
[31]
Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
[32]
Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan.
[33]
Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
[34]
Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
[35]
Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minnesota.
[36]
Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania.
[37]
Transplantation & Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland.
[38]
Cancer Treatment Centers of America Comprehensive Care and Research Center, Phoenix, Arizona.
[39]
Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, University of California, Irvine, Orange, California.
[40]
主题词
抗淋巴细胞血清(Antilymphocyte Serum);环磷酰胺(Cyclophosphamide);女(雌)性(Female);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);男(雄)性(Male);回顾性研究(Retrospective Studies)
DOI
10.1016/j.jtct.2022.07.013
PMID
35853610
发布时间
2023-10-02
- 浏览2
Transplantation and cellular therapy
Transplantation and cellular therapy
2022年28卷10期
681-693页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
